Clinical Insights on Zanubrutinib in Waldenström Macroglobulinemia: Efficacy, Safety, and Real-World Evidence
Waldenström’s macroglobulinemia (WM) is a rare, indolent type of Non-Hodgkin’s Lymphoma. WM is characterized by an abnormal increase of lymphoplasmacytic cells in the bone marrow which produces an excessive amount of monoclonal IgM. Most patients experience a slow progression of the disease; however, it can significantly affect the quality of life of patients because of […]









